1. Home
  2. IMRN vs BNRG Comparison

IMRN vs BNRG Comparison

Compare IMRN & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • BNRG
  • Stock Information
  • Founded
  • IMRN 1994
  • BNRG 2012
  • Country
  • IMRN Australia
  • BNRG Israel
  • Employees
  • IMRN N/A
  • BNRG N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • IMRN Health Care
  • BNRG
  • Exchange
  • IMRN Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • IMRN 10.1M
  • BNRG 10.0M
  • IPO Year
  • IMRN N/A
  • BNRG 2022
  • Fundamental
  • Price
  • IMRN $1.75
  • BNRG $1.31
  • Analyst Decision
  • IMRN Strong Buy
  • BNRG
  • Analyst Count
  • IMRN 1
  • BNRG 0
  • Target Price
  • IMRN $5.00
  • BNRG N/A
  • AVG Volume (30 Days)
  • IMRN 13.7K
  • BNRG 57.2K
  • Earning Date
  • IMRN 04-15-2025
  • BNRG 03-04-2025
  • Dividend Yield
  • IMRN N/A
  • BNRG N/A
  • EPS Growth
  • IMRN N/A
  • BNRG N/A
  • EPS
  • IMRN N/A
  • BNRG N/A
  • Revenue
  • IMRN $4,048,286.00
  • BNRG N/A
  • Revenue This Year
  • IMRN N/A
  • BNRG N/A
  • Revenue Next Year
  • IMRN N/A
  • BNRG N/A
  • P/E Ratio
  • IMRN N/A
  • BNRG N/A
  • Revenue Growth
  • IMRN 82.90
  • BNRG N/A
  • 52 Week Low
  • IMRN $1.70
  • BNRG $0.60
  • 52 Week High
  • IMRN $3.09
  • BNRG $3.27
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.07
  • BNRG 48.84
  • Support Level
  • IMRN $1.73
  • BNRG $1.19
  • Resistance Level
  • IMRN $2.09
  • BNRG $1.30
  • Average True Range (ATR)
  • IMRN 0.14
  • BNRG 0.09
  • MACD
  • IMRN 0.00
  • BNRG 0.00
  • Stochastic Oscillator
  • IMRN 10.26
  • BNRG 41.38

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: